Neuropilin‐1 is differentially expressed in myoepithelial cells and vascular smooth muscle cells in preneoplastic and neoplastic human breast: A possible marker for the progression of breast cancer

The expression and distribution of neuropilin‐1 (NRP‐1) was examined in the samples of normal human breast tissues and in non‐neoplastic and neoplastic areas of breast tissue removed for carcinoma using RT‐PCR as well as conventional and tissue microarrays immunohistochemical analyses. The NRP‐1 mRNA expression was significantly higher in neoplastic tissues as compared to normal breast samples. Immunohistochemically, the myoepithelial cells of the mammary ducts and lobules display positive reactions for NRP‐1, whereas the inner ductal and lobular epithelial cell layers failed to react. The myoepithelial cells of ducts and lobules in both neoplastic and non‐neoplastic tissue specimens displayed a stronger positive reaction for NRP‐1 than those in the normal breast. A positive reaction for NRP‐1, but with a gradual reduction in intensity, was observed in the myoepithelial cells of ducts with atypical epithelial hyperplasia and ductal carcinoma in situ (DCIS). The reaction was undetected or minimally detected in the areas of invasive carcinoma. NRP‐1 positive immunolabeling was also localized in the vascular smooth muscle cells and in some endothelial cells of the blood vessels in normal, non‐neoplastic and neoplastic breast tissue samples. In areas of breast carcinoma, NRP‐1 immunolabeling was more prominent in both vascular smooth muscle cells and in some endothelial cells than in similar cells in normal breast. The specificity of the newly developed antibody for NRP‐1 was confirmed by in situ hybridization with DIG‐labeled PCR generated probe. These results suggest that NRP‐1 may be a multiple function protein in human breast and may be involved in the induction of local invasiveness of neoplasia and angiogenesis and have direct relevance to the progression of breast cancer. © 2002 Wiley‐Liss, Inc.

[1]  U. Hellman,et al.  Differential Binding of Vascular Endothelial Growth Factor B Splice and Proteolytic Isoforms to Neuropilin-1* , 1999, The Journal of Biological Chemistry.

[2]  Shay Soker,et al.  Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor , 1998, Cell.

[3]  Hiroaki Kobayashi,et al.  Secreted Chick Semaphorins Bind Recombinant Neuropilin with Similar Affinities but Bind Different Subsets of Neurons In Situ , 1997, Neuron.

[4]  T. Kitsukawa,et al.  Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. , 1995, Development.

[5]  M. Shibuya,et al.  Neuropilin-1 Is a Placenta Growth Factor-2 Receptor* , 1998, The Journal of Biological Chemistry.

[6]  S. Soker,et al.  Neuropilin‐1 expression by tumor cells promotes tumor angiogenesis and progression , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  M. Tessier-Lavigne,et al.  Neuropilin Is a Receptor for the Axonal Chemorepellent Semaphorin III , 1997, Cell.

[8]  C. Goodman,et al.  Neuropilin-2, a Novel Member of the Neuropilin Family, Is a High Affinity Receptor for the Semaphorins Sema E and Sema IV but Not Sema III , 1997, Neuron.

[9]  T. Kitsukawa,et al.  Developmentally regulated expression of a cell surface protein, neuropilin, in the mouse nervous system. , 1996, Journal of neurobiology.

[10]  K. Garcia,et al.  The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1. , 2000, The Journal of biological chemistry.

[11]  K. Agata,et al.  The A5 antigen, a candidate for the neuronal recognition molecule, has homologies to complement components and coagulation factors , 1991, Neuron.

[12]  H. Fujisawa,et al.  Determination of Cell Adhesion Sites of Neuropilin-1 , 2000, The Journal of cell biology.

[13]  G. Neufeld,et al.  Neuropilin-2 and Neuropilin-1 Are Receptors for the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF) and of Placenta Growth Factor-2, but Only Neuropilin-2 Functions as a Receptor for the 145-Amino Acid Form of VEGF* , 2000, The Journal of Biological Chemistry.

[14]  D. Henson,et al.  The Pathology of Incipient Neoplasia , 1986 .

[15]  L. Ouafik,et al.  Differential expression and regulation of the vascular endothelial growth factor receptors neuropilin-1 and neuropilin-2 in rat uterus. , 2001, Endocrinology.

[16]  A. Weston,et al.  Overexpression of vascular endothelial growth factor164 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells. , 2000, International journal of oncology.

[17]  T. Amagai,et al.  Specific cell surface labels in the visual centers of Xenopus laevis tadpole identified using monoclonal antibodies. , 1987, Developmental biology.

[18]  Detlev Drenckhahn,et al.  Pericyte involvement in capillary sprouting during angiogenesis in situ , 1992, Cell and Tissue Research.

[19]  R. Cherian,et al.  Expression of cdc2 and cyclin B1 in Helicobacter pylori-associated gastric MALT and MALT lymphoma : relationship to cell death, proliferation, and transformation. , 2000, The American journal of pathology.

[20]  S. Takagi,et al.  Expression of a cell adhesion molecule, neuropilin, in the developing chick nervous system. , 1995, Developmental biology.

[21]  A. Ishida,et al.  Expression of vascular endothelial growth factor receptors in smooth muscle cells , 2001, Journal of cellular physiology.

[22]  A. Clowes,et al.  Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[23]  D. Sarkar,et al.  Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis. , 1997, Carcinogenesis.

[24]  M. Reidy,et al.  The role of plasminogen, plasminogen activators, and matrix metalloproteinases in primate arterial smooth muscle cell migration. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[25]  Alex L Kolodkin,et al.  Neuropilin Is a Semaphorin III Receptor , 1997, Cell.

[26]  M. Teresa Pisabarro,et al.  Analysis of PDZ Domain-Ligand Interactions Using Carboxyl-terminal Phage Display* , 2000, The Journal of Biological Chemistry.

[27]  S. Egginton,et al.  In vivo angiogenesis in adult rat skeletal muscle: early changes in capillary network architecture and ultrastructure , 1996, Cell and Tissue Research.

[28]  J. Keiser,et al.  Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. , 1998, Circulation research.

[29]  A. Newby,et al.  Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. , 1992, The Biochemical journal.

[30]  M. Reidy,et al.  Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. , 1994, Journal of vascular surgery.

[31]  A. Kolodkin,et al.  Steering Clear of Semaphorins: Neuropilins Sound the Retreat , 1997, Neuron.

[32]  S. Soker,et al.  Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Abrahamson,et al.  Coexpression of neuropilin-1, Flk1, and VEGF(164) in developing and mature mouse kidney glomeruli. , 2000, American journal of physiology. Renal physiology.

[34]  G. Neufeld,et al.  Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected]. , 2000, The Journal of biological chemistry.

[35]  R. Cherian,et al.  Tumor Angiogenesis in Chronic Pancreatitis and Pancreatic Adenocarcinoma: Impact of K-ras Mutations , 2000, Pancreas.

[36]  M. Klagsbrun,et al.  Neuropilin is a Mediator of Angiogenesis , 2004, Cancer and Metastasis Reviews.

[37]  P. Kelly,et al.  Implantation and decidualization defects in prolactin receptor (PRLR)-deficient mice are mediated by ovarian but not uterine PRLR. , 2000, Endocrinology.

[38]  S. Banerjee,et al.  WISP-2: a serum-inducible gene differentially expressed in human normal breast epithelial cells and in MCF-7 breast tumor cells. , 2001, Biochemical and biophysical research communications.